EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Echoes of Excellence
Volume 10 Issue 3

Echoes of Excellence

The management of cardiovascular disease (CVD) continues to present a major challenge to the NHS. Although morbidity has fallen by more than three-quarters since 1961...
Continue Reading →
Clinical Development in Challenging Cancers: Cholangiocarcinoma (CCA)
Volume 10 Issue 3

Clinical Development in Challenging Cancers: Cholangiocarcinoma (CCA)

Cholangiocarcinoma is a diverse malignancy that arises from the epithelium of the bile ducts and features differentiated cholangiocytes. CCA is a very challenging mal...
Continue Reading →
Enhancing Clinical Trials in Multiple System Atrophy
Volume 10 Issue 3

Enhancing Clinical Trials in Multiple System Atrophy

Multiple-system atrophy (MSA) is a rare progressive, neurodegenerative disease that is clinically characterised by autonomic failure in addition to various features o...
Continue Reading →
FDA/EMA-triggered Paediatric Studies Do Not Advance Child Healthcare
Volume 10 Issue 3

FDA/EMA-triggered Paediatric Studies Do Not Advance Child Healthcare

Both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) request/demand clinical studies in children sponsored by the pharmaceutical ind...
Continue Reading →
Advances in Technology that Support Electronic Data Capture (EDC) and Clinical Trial Management Systems
Volume 10 Issue 3

Advances in Technology that Support Electronic Data Capture (EDC) and Clinical Trial Management Systems

One of the critical elements in clinical trials is capturing data which is accurate and timely. EDC systems, software applications that allow users to enter informati...
Continue Reading →
Unmasking the Blind of Over-encapsulation
Volume 10 Issue 3

Unmasking the Blind of Over-encapsulation

A recent analysis conducted by the Tufts Center for the Study of Drug Development estimated that the average cost to develop and gain marketing approval for a new dru...
Continue Reading →
Quotient